Efficacy and safety of surufatinib plus PD-1/PD-L1 inhibitors as first-line maintenance therapy in extensive-stage small cell lung cancer.
| Publicado en: | Holistic Integrative Oncology Vol. 5; no. 1; pp. 1 - 11 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
7/28/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |